Novel Therapies in Glioblastoma

Conventional treatment of glioblastoma has advanced only incrementally in the last 30 years and still yields poor outcomes. The current strategy of surgery, radiation, and chemotherapy has increased median survival to approximately 15 months. With the advent of molecular biology and consequent impro...

Descripción completa

Detalles Bibliográficos
Autores principales: Perry, James, Okamoto, Masahiko, Guiou, Michael, Shirai, Katsuyuki, Errett, Allison, Chakravarti, Arnab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316989/
https://www.ncbi.nlm.nih.gov/pubmed/22530121
http://dx.doi.org/10.1155/2012/428565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316989/
https://www.ncbi.nlm.nih.gov/pubmed/22530121
http://dx.doi.org/10.1155/2012/428565

Ejemplares similares